Henry Schein, Inc. (HSIC) stock analysis
In our weekly check, Henry Schein, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 13 pass, warnings: 9, red flags: 2.
About Henry Schein, Inc.
Henry Schein, Inc. is a Healthcare company (Medical Distribution) based in the United States, listed on NASDAQ as HSIC.
What our checks show for HSIC
Red flags
- The net margin fell by 2 points over 5 years, to 3.1%: the company keeps less of each sale as profit.
- The net margin is only 3.1%: little room if costs rise.
Warning signs
- Net debt is 3.4x a year of EBITDA (debt/equity 1.23). That limits room in a downturn and raises refinancing risk.
- Analysts expect only about 3.8% a year of growth in revenue.
- Revenue grew only 2.8% a year over the last 3 years.
- Earnings per share fell 2.2% a year over the last 3 years.
- Net profit fell 7.8% a year over the last 3 years.
- Free cash flow is only 3.9% of revenue.
- The stock has fallen as much as 48% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 2.1 years.
- Return on capital (ROCE) is only 9.9%.
Strengths
- Operating cash flow is 1.63x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 29.4% a year over the next years.
- The share count fell by 7.5% in 2 years: the company buys back its own shares.
- Pay in shares is only 3% of free cash flow.
Similar companies
CAH · COR
Questions
What grade does Henry Schein, Inc. (HSIC) have?
In our weekly check, Henry Schein, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 13 pass, warnings: 9, red flags: 2. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of HSIC stock?
This week's biggest flags for Henry Schein, Inc.: Margins falling, Thin margins, High debt. In total 11 of 24 checks show a warning or a red flag.
What does Henry Schein, Inc. do?
Henry Schein, Inc. is a Healthcare company (Medical Distribution) based in the United States, listed on NASDAQ as HSIC.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis